Sanofi, GSK to supply US govt with 100 million doses of Covid-19 vaccine
The vaccine candidate, developed by Sanofi in partnership with GSK, is based on the recombinant protein-based technology used by Sanofi to produce an influenza vaccine, and GSK’s established